OA12186A - 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs. - Google Patents

4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs. Download PDF

Info

Publication number
OA12186A
OA12186A OA1200200266A OA1200200266A OA12186A OA 12186 A OA12186 A OA 12186A OA 1200200266 A OA1200200266 A OA 1200200266A OA 1200200266 A OA1200200266 A OA 1200200266A OA 12186 A OA12186 A OA 12186A
Authority
OA
OAPI
Prior art keywords
amino
pyridyl
dimethoxy
tetrahydroisoquinol
quinazoline
Prior art date
Application number
OA1200200266A
Other languages
English (en)
French (fr)
Inventor
Patricia Ann Basford
Paul Blaise Hodgson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005200A external-priority patent/GB0005200D0/en
Priority claimed from GB0015900A external-priority patent/GB0015900D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of OA12186A publication Critical patent/OA12186A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
OA1200200266A 2000-03-03 2001-02-23 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs. OA12186A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0005200A GB0005200D0 (en) 2000-03-03 2000-03-03 New salt form
GB0015900A GB0015900D0 (en) 2000-06-28 2000-06-28 New salt form

Publications (1)

Publication Number Publication Date
OA12186A true OA12186A (en) 2006-05-09

Family

ID=26243792

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200266A OA12186A (en) 2000-03-03 2001-02-23 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs.

Country Status (40)

Country Link
US (1) US6683085B2 (es)
EP (1) EP1268468B1 (es)
JP (1) JP3857919B2 (es)
KR (1) KR100496089B1 (es)
CN (1) CN1214029C (es)
AP (1) AP2002002611A0 (es)
AR (1) AR029482A1 (es)
AT (1) ATE253570T1 (es)
AU (1) AU779118B2 (es)
BG (1) BG106869A (es)
BR (1) BR0108910A (es)
CA (1) CA2398963C (es)
CR (1) CR6731A (es)
CZ (1) CZ20022858A3 (es)
DE (1) DE60101157T2 (es)
DK (1) DK1268468T3 (es)
EA (1) EA004748B1 (es)
EE (1) EE200200496A (es)
ES (1) ES2208565T3 (es)
GE (1) GEP20043364B (es)
HK (1) HK1053655A1 (es)
HN (1) HN2001000036A (es)
HR (1) HRP20020718A2 (es)
HU (1) HUP0300006A3 (es)
IL (1) IL150634A0 (es)
IS (1) IS6441A (es)
MA (1) MA26876A1 (es)
MX (1) MXPA02008665A (es)
NO (1) NO20024195L (es)
NZ (1) NZ519672A (es)
OA (1) OA12186A (es)
PE (1) PE20011225A1 (es)
PL (1) PL365070A1 (es)
PT (1) PT1268468E (es)
SI (1) SI1268468T1 (es)
SK (1) SK12282002A3 (es)
TN (1) TNSN01034A1 (es)
TR (1) TR200302130T4 (es)
UA (1) UA72311C2 (es)
WO (1) WO2001064672A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124455D0 (en) * 2001-10-11 2001-12-05 Pfizer Ltd Pharmaceutical formulations
US7163696B2 (en) 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
DE10223913A1 (de) * 2002-05-29 2003-12-11 Bayer Cropscience Ag Verfahren zur Herstellung spezifischer Kristallmodifikationen polymorpher Substanzen
GB0221582D0 (en) * 2002-09-17 2002-10-23 Pfizer Ltd Method of treatment
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2005089804A2 (en) * 2004-03-16 2005-09-29 Pfizer Limited Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists
CN101584696A (zh) * 2008-05-21 2009-11-25 上海艾力斯医药科技有限公司 包含喹唑啉衍生物的组合物及制备方法、用途
CN105596301A (zh) * 2016-01-29 2016-05-25 中国药科大学 一种以异喹啉为基本骨架的p2x7受体拮抗剂的纳米混悬剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914114A (en) 1984-05-28 1990-04-03 Merck Patent Gesellschaft Mit Breschrankter Haftung 3-[4-(4-phenyl-1,2,3,6-tetrahydro-1-pyridyl)butyl]-5-hydroxy-indole methanesulfonate having sedating and anti-parkinsonism properties
AU594512B2 (en) * 1986-09-16 1990-03-08 Merck Patent Gesellschaft Mit Beschrankter Haftung Hydroxy indole derivatives
GB9700504D0 (en) * 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
EA004748B1 (ru) 2004-08-26
HUP0300006A2 (en) 2003-05-28
HN2001000036A (es) 2001-07-09
PT1268468E (pt) 2004-01-30
JP2003525289A (ja) 2003-08-26
UA72311C2 (uk) 2005-02-15
AU3588801A (en) 2001-09-12
PL365070A1 (en) 2004-12-27
EE200200496A (et) 2004-02-16
KR100496089B1 (ko) 2005-06-17
AR029482A1 (es) 2003-07-02
BR0108910A (pt) 2002-12-24
PE20011225A1 (es) 2001-12-08
EP1268468B1 (en) 2003-11-05
BG106869A (bg) 2002-12-29
DE60101157T2 (de) 2004-09-02
HK1053655A1 (en) 2003-10-31
AU779118B2 (en) 2005-01-06
SI1268468T1 (en) 2004-04-30
CR6731A (es) 2004-03-11
IS6441A (is) 2002-06-25
NO20024195D0 (no) 2002-09-03
CA2398963C (en) 2006-10-24
CA2398963A1 (en) 2001-09-07
MXPA02008665A (es) 2003-02-24
NO20024195L (no) 2002-09-03
EP1268468A1 (en) 2003-01-02
MA26876A1 (fr) 2004-12-20
NZ519672A (en) 2004-06-25
SK12282002A3 (sk) 2003-10-07
US20020010188A1 (en) 2002-01-24
TNSN01034A1 (fr) 2005-11-10
KR20020080463A (ko) 2002-10-23
GEP20043364B (en) 2004-03-10
IL150634A0 (en) 2003-02-12
CN1214029C (zh) 2005-08-10
CN1432010A (zh) 2003-07-23
DK1268468T3 (da) 2004-02-09
HUP0300006A3 (en) 2006-01-30
ATE253570T1 (de) 2003-11-15
EA200200826A1 (ru) 2003-02-27
CZ20022858A3 (cs) 2003-09-17
US6683085B2 (en) 2004-01-27
AP2002002611A0 (en) 2002-09-30
WO2001064672A1 (en) 2001-09-07
JP3857919B2 (ja) 2006-12-13
DE60101157D1 (de) 2003-12-11
TR200302130T4 (tr) 2004-01-21
ES2208565T3 (es) 2004-06-16
HRP20020718A2 (en) 2004-02-29

Similar Documents

Publication Publication Date Title
DK2328414T3 (en) Substituted triazolopyridazine derivatives
JP3834098B2 (ja) ベンゾニトリル類およびベンゾフルオリド類
IL178097A (en) Polymorphs of IMATINIB acid addition salts with tensulfonic acid
WO2017016463A1 (zh) Egfr抑制剂及其药学上可接受的盐和多晶型物及其应用
TW200812970A (en) Inhibitors of AKT (protein kinase B)
OA12186A (en) 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs.
US20080287411A1 (en) Optically active dihydropyridine derivative
KR100479897B1 (ko) 다형태 염
US5106850A (en) Indole derivatives
JPH04217955A (ja) 置換ベンズインドールイミン誘導体及びその製法
JPS601310B2 (ja) イミダゾリン化合物の製法
HU223963B1 (hu) Piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények
ZA200207016B (en) 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs.
AU690556B2 (en) Use of benzenesulphonylindole derivatives for the preparation of medicines
JP2815691B2 (ja) Ｋｒｎ２３９１酸付加塩およびその用途
TW201125861A (en) CDC7 inhibitor salts
JP2023531078A (ja) 化合物の結晶形態
WO2013010502A1 (zh) 一种普拉格雷的酸加成盐及其制备方法和用途
WO2011016686A2 (en) Prasugrel disulfonate or crystalline forms thereof, method for preparing same, and pharmaceutical composition containing same
KR20000075735A (ko) 심혈관 작용제로서의 2-아미노-1,2,3,4-테트라히드로나프탈렌의 히드록시메틸 유도체